Literature DB >> 21339021

[A prescription register incorporated into computerized medical records for patients with hypertension: a new instrument to evaluate medication adherence].

José Miguel Baena-Díez1, Claudia Gómez-Fernández, Mónica Vilató-García, Ernesto Javier Vásquez-Lazo, Alice Olivia Byram, Marc Vidal-Solsona.   

Abstract

OBJECTIVE: To study the validity of a prescription register (PR) incorporated into computerized medical records (CMR) compared with the Morisky-Green test in patients with high blood pressure using anti-hypertensive medication.
DESIGN: Cross-sectional study.
SETTING: Primary Care. PARTICIPANTS: A total of 252 patients with hypertension using drug therapy with no changes in drugs or dosage were randomly selected. MAIN MEASUREMENTS: Descriptive variables, blood pressure, proportion of drug therapy collected from pharmacies according to the PR over 12 months compared with drug therapy prescribed in CMR (poor medication adherence [MA] if <80%), and Morisky-Green test. Validity of the PR was analysed using the Kappa index to compare PR with the Morisky-Green test (reference) and blood pressure levels.
RESULTS: Mean age was 68 years, 50% were women, and 77% completed the study. Poor MA was 51.3% according to the PR (95% CI 44.3%-58.3%) and 15.4% (95% CI; 10.3%-20.4%) when using the Morisky-Green test. The Kappa index was -0.068. Patients with poor MA according to the PR had higher levels of systolic and diastolic blood pressure (4.3 and 2.9 mmHg, respectively, P<0.05). No differences in blood pressure were observed in patients with poor MA if the Morisky-Green test was used (0.1 and 1 mmHg, respectively, P>0.05).
CONCLUSIONS: Poor MA according to the PR is high and is associated with poorer control of blood pressure; the Morisky-Green test does not pick up on these differences. These results suggest that the PR could be useful for evaluating MA and that the Morisky-Green test underestimates poor MA.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339021      PMCID: PMC7025024          DOI: 10.1016/j.aprim.2010.04.018

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  16 in total

1.  [Treatment adherence and persistence: causes, consequences and improvement strategies].

Authors:  Tatiana Dilla; Amparo Valladares; Luis Lizán; José Antonio Sacristán
Journal:  Aten Primaria       Date:  2009-05-07       Impact factor: 1.137

2.  [Hypertension and health policy in Spain].

Authors:  José R Banegas; Albert Jovell; Benjamín Abarca; Manuel Aguilar Diosdado; Luis Aguilera; Pedro Aranda; Vicente Bertoméu; Pedro Capilla; Pedro Conthe; Fernando De Alvaro; Antonio Fernández-Pro; Xavier Formiguera; Jesús Frías; Lucía Guerrero; José L Llisterri; José M Lobos; Juan F Macías; Angel L Martín De Francisco; Jesús Millán; Juan C Morales; Vicente Palomo; Alex Roca-Cusachs; Javier Román; Carlos Sanchis; Antonio Sarriá; Julián Segura; Alex De La Sierra; Luis Verde; Julio Zarco; Luis M Ruilope
Journal:  Med Clin (Barc)       Date:  2009-02-12       Impact factor: 1.725

3.  [Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005].

Authors:  Emilio Márquez Contreras; Vicente Gil Guillén; José Joaquín Casado Martínez; Nieves Martel Claros; Mariano De la Figuera von Wichmann; José Luis Martín de Pablos; Francisco Atienza Martín; Teresa Gros García; Jacinto Espinosa García
Journal:  Aten Primaria       Date:  2006-10-15       Impact factor: 1.137

4.  [Review of the test used for measuring therapeutic compliance in clinical practice].

Authors:  Miguel Angel Rodríguez Chamorro; Emilio García-Jiménez; Pedro Amariles; Alfonso Rodríguez Chamorro; María José Faus
Journal:  Aten Primaria       Date:  2008-08       Impact factor: 1.137

Review 5.  [Causes of the bad control of arterial pressure in Spain].

Authors:  A Puras Tellaeche
Journal:  Aten Primaria       Date:  1998-05-31       Impact factor: 1.137

Review 6.  How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials.

Authors:  Knut Schroeder; Tom Fahey; Shah Ebrahim
Journal:  Arch Intern Med       Date:  2004-04-12

7.  [Reasons for therapy non-compliance in older patients taking multiple medication].

Authors:  José Antonio Escamilla Fresnadillo; Olga Castañer Niño; Sandra Benito López; Eulalia Ruiz Gil; Montse Burrull Gimeno; Nerea Sáenz Moya
Journal:  Aten Primaria       Date:  2008-02       Impact factor: 1.137

8.  [Non-pharmacological intervention as a strategy to improve antihypertensive treatment compliance].

Authors:  Emilio Márquez Contreras; Nieves Martel Claros; Vicente Gil Guillén; José Luis Martín De Pablos; Mariano De la Figuera Von Wichman; José Joaquín Casado Martínez; Jacinto Espinosa García; José Carlos Pastoriza Vilas
Journal:  Aten Primaria       Date:  2009-06-03       Impact factor: 1.137

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  [Study on the use of a smart pillbox to improve treatment compliance].

Authors:  María Teresa Morales Suárez-Varela
Journal:  Aten Primaria       Date:  2009-03-28       Impact factor: 1.137

View more
  2 in total

1.  [Therapeutic adherence. How difficult it is to comply!].

Authors:  Francisco Buitrago
Journal:  Aten Primaria       Date:  2011-06-11       Impact factor: 1.137

2.  Medication Adherence In Patients With Arterial Hypertension: The Relationship With Healthcare Systems' Organizational Factors.

Authors:  Ana Sofia Carvalho; Paulo Santos
Journal:  Patient Prefer Adherence       Date:  2019-10-17       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.